Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

Conclusions: Eltrombopag plus pulsed dexamethasone is an effective and safe treatment for ITP as a first line therapy that can provide sustained prolonged response in adults. This therapy could be a new treatment option for ITP subjects.DisclosuresCheng: Novartis: Research Funding; BMS: Honoraria, Speakers Bureau; Astrazeneca: Honoraria, Speakers Bureau.

Source: Blood - November 21, 2018 Category: Hematology Authors: Zhang, L., Zhang, M., Du, X., Cheng, Y., Cheng, G. Tags: 311. Disorders of Platelet Number or Function: Advances in the Treatment of ITP Source Type: research